Showing results (61-70 of 4,413) with videos related to
Sort By:
Pageof 442
Critical Reviews in Oncology/Hematology|March 15, 2016
Diagnostic accuracy of serum biomarkers for head and neck cancer: A systematic review and meta-analysisEliete Neves Silva Guerra, Daniela Fortunato Rêgo, Silvia Taveira Elias, et al.Critical Reviews in Oncology/Hematology|March 12, 2016
Ovarian cancer: Status of homologous recombination pathway as a predictor of drug responseNicolas De Picciotto, Wulfran Cacheux, Arnaud Roth, et al.Critical Reviews in Oncology/Hematology|March 14, 2016
PET-adapted omission of radiotherapy in early stage Hodgkin lymphoma-a systematic review and meta-analysisMarie T Sickinger, Bastian von Tresckow, Carsten Kobe, et al.Critical Reviews in Oncology/Hematology|June 22, 2016
Reporting adverse events in cancer surgery randomized trials: A systematic review of published trials in oesophago-gastric and gynecological cancer patientsLeila Meghelli, Fabrice Narducci, Christophe Mariette, et al.Critical Reviews in Oncology/Hematology|June 12, 2016
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendationsS Novello, C Pinto, V Torri, et al.Critical Reviews in Oncology/Hematology|June 15, 2016
Review on TAS-102 development and its use for metastatic colorectal cancerJose Mauricio Mota, Leonardo G Fonseca, Maria Ignez Braghiroli, et al.Critical Reviews in Oncology/Hematology|April 25, 2012
Turning promise into progress for antiangiogenic agents in epithelial ovarian cancerArne R M van der Bilt, Elisabeth G E de Vries, Steven de Jong, et al.Critical Reviews in Oncology/Hematology|May 12, 2012
Angiogenesis: a promising therapeutic target for ovarian cancerA Bamias, S Pignata, E Pujade-LauraineCritical Reviews in Oncology/Hematology|September 15, 2015
Dominant mechanisms of primary resistance differ from dominant mechanisms of secondary resistance to targeted therapiesKsenija AsićCritical Reviews in Oncology/Hematology|September 15, 2015
Signaling mechanisms of resistance to EGFR- and Anti-Angiogenic Inhibitors cancerGiovanna Mirone, Arvind Shukla, Gabriella MarfePageof 442